Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland

Title
Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland
Authors
Keywords
Ulcerative colitis, Cost-utility, Adalimumab, Economic analysis, Indirect costs
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 72, Issue 11, Pages 1319-1325
Publisher
Springer Nature
Online
2016-08-06
DOI
10.1007/s00228-016-2103-4

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started